Alexander C Lee, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location · Alexander C Lee MD A Medical Corporation · 2 clinicians in this group
Looking this up.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office at (408) 502-6188 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
California Medical Board record
Licence A87178 · Current
Licensed to practise in California · since 2004 · expires 2028-04-30 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$43,673
Medicare paid this office $43,673 for 90 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 63 | $20,239 | $116 |
| Exam of visual field with extended testing | 52 | $4,870 | $62 |
| Established patient complete exam of visual system | 42 | $4,592 | $96 |
| New patient visit (45+ min) | 23 | $2,798 | $122 |
| Imaging of optic nerve | 48 | $1,998 | $34 |
See all 10 services
| Return visit (30+ min) | 63 | $20,239 | $116 |
| Exam of visual field with extended testing | 52 | $4,870 | $62 |
| Established patient complete exam of visual system | 42 | $4,592 | $96 |
| New patient visit (45+ min) | 23 | $2,798 | $122 |
| Imaging of optic nerve | 48 | $1,998 | $34 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 61 | $1,837 | $15 |
| Exam of the internal drainage system of eye | 53 | $1,384 | $26 |
| Photography of the retina | 35 | $1,192 | $34 |
| Imaging of retina | 12 | $606 | $38 |
| Ultrasound scan of cornea to determine thickness | 11 | $112 | $10 |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
90 Original Medicare patients in 2024. Average age 73 · Women 46% · Health risk score 0.81. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 60% · Diabetes 30% · Cancer 14% · Coronary heart disease 13% · Chronic kidney disease 12%.
The office billed $91,479, Medicare allowed $60,160 and paid $43,673; for 639 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 90 | 639 | 73 | 0.81 | $91,479 | $43,673 |
| 2023 | 82 | 372 | 74 | 0.88 | $75,447 | $36,075 |
| 2022 | 488 | 732 | 81 | 2.02 | $137,496 | $80,744 |
| 2021 | 2,196 | 3,204 | 80 | 2.18 | $567,051 | $394,257 |
| 2020 | 2,214 | 2,753 | 81 | 2.11 | $452,375 | $336,598 |
| 2019 | 3,834 | 5,703 | 81 | 2.36 | $946,399 | $684,519 |
| 2018 | 3,950 | 6,002 | 81 | 2.31 | $963,848 | $640,139 |
| 2017 | 3,759 | 5,947 | 81 | 2.33 | $911,926 | $595,168 |
| 2016 | 3,558 | 5,615 | 82 | 2.57 | $898,719 | $611,295 |
| 2015 | 3,519 | 5,505 | 82 | 2.42 | $874,186 | $594,633 |
| 2014 | 3,610 | 5,907 | 81 | 2.34 | $903,103 | $604,138 |
| 2013 | 3,252 | 5,472 | 82 | 2.24 | $801,790 | $542,720 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 39 | $10,045 | $114 |
| Established patient complete exam of visual system | 54 | $8,294 | $111 |
| New patient visit (45+ min) | 25 | $3,931 | $157 |
| Exam of visual field with extended testing | 38 | $3,333 | $58 |
| Imaging of optic nerve | 31 | $1,378 | $34 |
| Photography of the retina | 23 | $857 | $37 |
| Exam of the internal drainage system of eye | 22 | $602 | $26 |
2022: 9 services
| Established patient complete exam of visual system | 337 | $43,858 | $119 |
| New patient complete exam of visual system | 92 | $12,770 | $139 |
| Return visit (30+ min) | 27 | $6,057 | $119 |
| Established patient problem focused exam of visual system | 54 | $4,966 | $86 |
| Exam of visual field with extended testing | 28 | $2,365 | $61 |
| New patient visit (45+ min) | 13 | $1,969 | $151 |
| Exam of the internal drainage system of eye | 36 | $993 | $28 |
| Imaging of optic nerve | 21 | $980 | $36 |
| Photography of the retina | 20 | $709 | $35 |
2021: 8 services
| Established patient complete exam of visual system | 1,511 | $254,674 | $125 |
| New patient complete exam of visual system | 761 | $110,920 | $146 |
| Established patient problem focused exam of visual system | 132 | $11,565 | $88 |
| Return visit (30+ min) | 23 | $7,433 | $124 |
| Exam of the internal drainage system of eye | 122 | $3,336 | $27 |
| Exam of visual field with extended testing | 18 | $1,729 | $66 |
| New patient problem focused exam of visual system | 18 | $1,466 | $81 |
| Imaging of optic nerve | 20 | $783 | $37 |
2020: 5 services
| Established patient complete exam of visual system | 1,614 | $234,643 | $121 |
| New patient complete exam of visual system | 588 | $85,878 | $146 |
| Established patient problem focused exam of visual system | 70 | $7,148 | $88 |
| Exam of the internal drainage system of eye | 83 | $2,265 | $27 |
| Exam of visual field with extended testing | 15 | $1,370 | $65 |
2019: 6 services
| Established patient complete exam of visual system | 2,801 | $484,138 | $118 |
| New patient complete exam of visual system | 1,252 | $172,646 | $138 |
| Established patient problem focused exam of visual system | 122 | $15,037 | $84 |
| Exam of visual field with extended testing | 15 | $1,614 | $65 |
| Exam of the internal drainage system of eye | 49 | $1,228 | $25 |
| Imaging of optic nerve | 12 | $542 | $36 |
2018: 7 services
| Established patient complete exam of visual system | 2,817 | $432,340 | $108 |
| New patient complete exam of visual system | 1,256 | $160,965 | $128 |
| Established patient problem focused exam of visual system | 379 | $33,553 | $76 |
| Exam of the internal drainage system of eye | 217 | $4,962 | $23 |
| New patient problem focused exam of visual system | 37 | $2,598 | $70 |
| New patient visit (45+ min) | 12 | $1,723 | $144 |
| Exam of visual field with extended testing | 18 | $1,581 | $63 |
2017: 7 services
| Established patient complete exam of visual system | 2,426 | $356,629 | $109 |
| New patient complete exam of visual system | 1,086 | $141,526 | $130 |
| Established patient problem focused exam of visual system | 798 | $71,374 | $76 |
| Exam of the internal drainage system of eye | 505 | $11,814 | $23 |
| New patient problem focused exam of visual system | 104 | $7,478 | $72 |
| New patient visit (45+ min) | 11 | $1,672 | $152 |
| Exam of visual field with extended testing | 14 | $1,233 | $65 |
2016: 6 services
| Established patient complete exam of visual system | 2,332 | $366,057 | $112 |
| New patient complete exam of visual system | 1,189 | $161,205 | $136 |
| Established patient problem focused exam of visual system | 655 | $60,317 | $80 |
| New patient problem focused exam of visual system | 93 | $6,872 | $74 |
| Exam of the internal drainage system of eye | 253 | $6,214 | $24 |
| Exam of visual field with extended testing | 15 | $1,221 | $64 |
2015: 6 services
| Established patient complete exam of visual system | 2,389 | $372,517 | $112 |
| New patient complete exam of visual system | 1,111 | $150,267 | $135 |
| Established patient problem focused exam of visual system | 547 | $48,497 | $78 |
| Exam of the internal drainage system of eye | 320 | $7,782 | $24 |
| New patient problem focused exam of visual system | 58 | $4,272 | $74 |
| New patient visit (45+ min) | 16 | $2,322 | $145 |
2014: 5 services
| Established patient complete exam of visual system | 2,306 | $357,614 | $111 |
| New patient complete exam of visual system | 1,147 | $152,587 | $133 |
| Established patient problem focused exam of visual system | 802 | $69,721 | $77 |
| Exam of the internal drainage system of eye | 496 | $12,233 | $25 |
| New patient problem focused exam of visual system | 106 | $7,766 | $73 |
2013: 5 services
| Established patient complete exam of visual system | 2,015 | $304,847 | $113 |
| New patient complete exam of visual system | 1,004 | $132,545 | $132 |
| Established patient problem focused exam of visual system | 849 | $82,215 | $78 |
| Exam of the internal drainage system of eye | 619 | $14,992 | $24 |
| New patient problem focused exam of visual system | 99 | $7,418 | $75 |
Medicaid work
$2,682 in 2022
Medicaid paid $2,682 for 625 billed services this clinician did in 2022, up to 102 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 129 | $2,471 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 23 | $211 |
| TOBACCO NON-USER | 145 | $0 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 102 | $0 |
| Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed; with evidence of retinopathy (DM) | 31 | $0 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 13 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 102 | $0 |
| Bp scrn perf rec interval | 13 | $0 |
| Patient not eligible due to active diagnosis of hypertension | 54 | $0 |
| Mac exam perf | 13 | $0 |
| 2022 | 625 | 10 | 102 | $2,682 |
| 2021 | 3,904 | 12 | 154 | $10,522 |
| 2020 | 3,501 | 13 | 221 | $9,495 |
| 2019 | 2,087 | 5 | 133 | $22,966 |
| 2018 | 1,598 | 5 | 148 | $17,703 |
See the largest Medicaid services in earlier years
2021
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 147 | $5,821 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 760 | $2,877 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 246 | $1,587 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 45 | $175 |
| GONIOSCOPY | 14 | $62 |
| TOBACCO NON-USER | 920 | $0 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 571 | $0 |
| Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed; with evidence of retinopathy (DM) | 219 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 571 | $0 |
| Bp scrn perf rec interval | 47 | $0 |
| Patient not eligible due to active diagnosis of hypertension | 351 | $0 |
| Mac exam perf | 13 | $0 |
2020
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 145 | $5,479 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 831 | $2,815 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 198 | $1,201 |
| TOBACCO NON-USER | 834 | $0 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 356 | $0 |
| OPTIC NERVE HEAD EVALUATION PERFORMED | 55 | $0 |
| Counseling about the benefits and/or risks of the Age-Related Eye Disease Study (AREDS) formulation for preventing progression of age-related macular degeneration (AMD) provided to patient and/or caregiver(s) (EC) | 16 | $0 |
| Dil retinal eye exam | 93 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 356 | $0 |
| Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 354 | $0 |
| Bp scrn perf rec interval | 15 | $0 |
| Patient not eligible due to active diagnosis of hypertension | 232 | $0 |
2019
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 381 | $14,521 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 1,010 | $6,984 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 265 | $1,430 |
| Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed; with evidence of retinopathy (DM) | 82 | $30 |
| TOBACCO NON-USER | 349 | $0 |
2018
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 352 | $13,464 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 805 | $3,154 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 224 | $855 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 31 | $200 |
| Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed; with evidence of retinopathy (DM) | 186 | $30 |
Drugs they prescribed that Part D paid
$59,538
Pharmacies billed $59,538 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 420) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
225 generic and 195 brand-name prescriptions · $59,538 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rhopressa | 29 | $13,419 | $463 |
| Restasis | 14 | $10,556 | $754 |
| Lumigan | 22 | $9,455 | $430 |
| Bimatoprost | 23 | $1,762 | $77 |
| Acetazolamide Er | 17 | $940 | $55 |
See all 12 drugs
| Rhopressa | 29 | $13,419 | $463 |
| Restasis | 14 | $10,556 | $754 |
| Lumigan | 22 | $9,455 | $430 |
| Bimatoprost | 23 | $1,762 | $77 |
| Acetazolamide Er | 17 | $940 | $55 |
| Dorzolamide-Timolol | 28 | $758 | $27 |
| Latanoprost | 96 | $711 | $7 |
| Prednisolone Acetate | 13 | $612 | $47 |
| Dorzolamide | 34 | $549 | $16 |
| Neomycin-Polymyxin-Dexameth | 13 | $156 | $12 |
| Brimonidine | 17 | $155 | $9 |
| Timolol Maleate | 34 | $149 | $4 |
Year by year
| 2024 | 420 | 73 | 0% (0) | 46% | $59,538 |
| 2023 | 253 | 43 | 0% (0) | 47% | $54,523 |
| 2022 | 315 | 47 | 0% (0) | 38% | $50,449 |
| 2021 | 374 | 71 | 0% (0) | 34% | $38,099 |
| 2020 | 580 | 90 | 0% (0) | 24% | $33,005 |
| 2019 | 771 | 144 | 0% (0) | 17% | $27,897 |
| 2018 | 711 | 115 | 0% (0) | 40% | $42,541 |
| 2017 | 564 | 80 | 0% (0) | 27% | $36,382 |
| 2016 | 348 | 51 | 0% (0) | 30% | $24,213 |
| 2015 | 266 | 37 | 0% (0) | 43% | $18,495 |
| 2014 | 175 | 27 | 0% (0) | 66% | $14,824 |
| 2013 | 188 | 37 | 0% (0) | 44% | $12,347 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Restasis | 17 | $13,854 | $815 |
| Lumigan | 29 | $12,104 | $417 |
| Brimonidine Tartrate-Timolol | 18 | $3,717 | $207 |
| Latanoprost | 45 | $907 | $20 |
| Bimatoprost | 11 | $896 | $81 |
| Dorzolamide | 12 | $431 | $36 |
| Acetazolamide Er | 15 | $395 | $26 |
| Dorzolamide-Timolol | 13 | $352 | $27 |
| Brimonidine | 14 | $57 | $4 |
2022: 11 drugs
| Restasis | 23 | $16,168 | $703 |
| Lumigan | 19 | $9,590 | $505 |
| Combigan | 14 | $6,100 | $436 |
| Rocklatan | 15 | $5,319 | $355 |
| Dorzolamide | 44 | $2,054 | $47 |
| Latanoprost | 70 | $1,467 | $21 |
| Dorzolamide-Timolol | 12 | $521 | $43 |
| Acetazolamide Er | 14 | $506 | $36 |
| Brimonidine | 19 | $199 | $10 |
| Neomycin-Polymyxin-Dexameth | 11 | $116 | $11 |
| Timolol Maleate | 16 | $75 | $5 |
2021: 7 drugs
| Restasis | 19 | $11,124 | $585 |
| Lumigan | 17 | $8,515 | $501 |
| Rhopressa | 18 | $4,813 | $267 |
| Latanoprost | 148 | $3,239 | $22 |
| Dorzolamide | 57 | $2,681 | $47 |
| Dorzolamide-Timolol | 20 | $696 | $35 |
| Brimonidine | 29 | $306 | $11 |
2020: 7 drugs
| Restasis | 17 | $8,466 | $498 |
| Lumigan | 20 | $7,590 | $379 |
| Latanoprost | 295 | $5,609 | $19 |
| Dorzolamide | 115 | $4,170 | $36 |
| Dorzolamide-Timolol | 17 | $888 | $52 |
| Brimonidine | 59 | $713 | $12 |
| Nystop | 13 | $624 | $48 |
2019: 6 drugs
| Latanoprost | 432 | $7,185 | $17 |
| Lumigan | 14 | $6,254 | $447 |
| Dorzolamide | 136 | $5,064 | $37 |
| Brimonidine | 101 | $1,836 | $18 |
| Dorzolamide-Timolol | 29 | $1,654 | $57 |
| Neomycin-Polymyxin-Dexameth | 13 | $227 | $17 |
2018: 7 drugs
| Travatan Z | 32 | $8,398 | $262 |
| Latanoprost | 425 | $7,765 | $18 |
| Lumigan | 30 | $7,280 | $243 |
| Cosopt Pf | 12 | $3,458 | $288 |
| Brimonidine | 89 | $2,863 | $32 |
| Dorzolamide | 52 | $1,670 | $32 |
| Dorzolamide-Timolol | 23 | $644 | $28 |
2017: 8 drugs
| Travatan Z | 50 | $11,286 | $226 |
| Xiidra | 14 | $5,131 | $367 |
| Latanoprost | 279 | $4,975 | $18 |
| Lumigan | 26 | $4,277 | $165 |
| Dorzolamide | 79 | $3,031 | $38 |
| Dorzolamide-Timolol | 35 | $1,142 | $33 |
| Brimonidine | 29 | $542 | $19 |
| Timolol Maleate | 13 | $187 | $14 |
2016: 6 drugs
| Travatan Z | 55 | $10,529 | $191 |
| Lumigan | 13 | $2,533 | $195 |
| Latanoprost | 135 | $2,095 | $16 |
| Dorzolamide | 50 | $1,973 | $39 |
| Brimonidine | 34 | $821 | $24 |
| Dorzolamide-Timolol | 18 | $494 | $27 |
2015: 5 drugs
| Travatan Z | 79 | $11,659 | $148 |
| Latanoprost | 82 | $1,126 | $14 |
| Dorzolamide | 25 | $542 | $22 |
| Dorzolamide-Timolol | 19 | $412 | $22 |
| Brimonidine | 24 | $320 | $13 |
2014: 4 drugs
| Travatan Z | 85 | $10,536 | $124 |
| Lumigan | 14 | $2,020 | $144 |
| Brimonidine | 33 | $450 | $14 |
| Latanoprost | 14 | $244 | $17 |
2013: 3 drugs
| Travatan Z | 81 | $10,082 | $124 |
| Brimonidine | 60 | $989 | $16 |
| Latanoprost | 14 | $269 | $19 |
Money from drug and device companies
$20 in 2025
| 2025 | 1 | 1 | $20 | $20 |
| 2020 | 1 | 1 | None | $19 |
| 2019 | 1 | 1 | None | $103 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| CooperVision | Misight Contact Lens | $20 | 1 payment
|
See the published payment
| CooperVision | Consulting · 2025-12-19 | Misight Contact Lens | $20 |
See earlier years (2020, 2019)
2020: $19
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
2019: $103
| Johnson & Johnson Surgical Vision | Catalys Laser System | $103 | 1 payment
|
Professional record
- NPI
- 1497834147
- Licence
- CA A87178California A87178: Current · expires 2028-04-30
- Trained
- University of California, San Diego School of Medicine, 2000
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A871780
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 706 N Genevieve Ln, San Jose, CA, 95128
- NPI first listed
- 2006-11-03
- NPI last updated
- 2016-05-20
This is when the NPI record was last certified, not a medical board exam.